Skip to content

Illumina ILMN Return on equity

Return on equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
13.5%-0.2pp
Guardant Health logo
Guardant HealthGH
-438.1%-1,655pp
Natera, Inc. logo
Natera, Inc.NTRA
-29%+4.1pp
Agilent Technologies logo
Agilent TechnologiesA
21.3%+2.4pp
Danaher logo
DanaherDHR
7.1%-0.1pp
Abbott logo
AbbottABT
12.4%-18.4pp

Other financials

Income statement

See full
Revenue$1.1B+4.8%
Gross profit$721.0M+5.6%
Operating income$209.0M+27.4%
Net income$134.0M+2.3%
EPS (diluted)$0.87+6.1%

Balance sheet

See full
Cash & equivalents$1.1B-2.2%
Total debt$2.0B-3.0%
Total equity$2.7B+13.0%
Total assets$6.6B+6.1%

Cash flow

See full
Operating cash flow$289.0M+20.4%
CapEx$38.0M+18.8%
Free cash flow$251.0M+20.7%

Valuation

See full
Market cap$24.07B+50.0%
Enterprise value$25.03B+46.0%
P/E28.2×
P/S5.5×+1.8×

Profitability

See full
Gross margin66.2%-0.1pp
Operating margin19.4%
Net margin19.4%+12.7pp

Returns & leverage

See full
Debt / equity0.8×-0.1×
Current ratio1.7×-0.1×

Where this comes from

Calculated from Illumina’s reported figures.

Based on trailing twelve months.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's return on equity?
Illumina (ILMN) reported return on equity of 33.8% in Q1 2026.
How has Illumina's return on equity changed year-over-year?
Illumina's return on equity increased by 241.8% year-over-year, from -23.8% to 33.8%.
What is the long-term trend for Illumina's return on equity?
Over 4 years (2021 to 2025), Illumina's return on equity has grown at a 21.0% compound annual growth rate (CAGR), from 50.7% to 108.7%.
What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.